Loading clinical trials...
Loading clinical trials...
A Multi-Center, Parallel Group, Flexible Dose Trial With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Assess The Impact Of Viagra On The Sexual Satisfaction Of Men With Mild Erectile Dysfunction
Conditions
Interventions
Viagra (Sildenafil citrate)
Locations
26
Canada
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Langley, British Columbia, Canada
Pfizer Investigational Site
Surrey, British Columbia, Canada
Pfizer Investigational Site
Vancouver, British Columbia, Canada
Start Date
November 1, 2005
Primary Completion Date
September 1, 2007
Completion Date
September 1, 2007
Last Updated
February 1, 2021
NCT03830164
NCT00151463
NCT00245258
NCT00906269
NCT02472431
NCT00498680
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions